174 related articles for article (PubMed ID: 36404323)
21. Hematogenous extramedullary relapse in multiple myeloma - a multicenter retrospective study in 127 patients.
Avivi I; Cohen YC; Suska A; Shragai T; Mikala G; Garderet L; Seny GM; Glickman S; Jayabalan DS; Niesvizky R; Gozzetti A; Wiśniewska-Piąty K; Waszczuk-Gajda A; Usnarska-Zubkiewicz L; Hus I; Guzicka R; Radocha J; Milunovic V; Davila J; Gentile M; Castillo JJ; Jurczyszyn A
Am J Hematol; 2019 Oct; 94(10):1132-1140. PubMed ID: 31334859
[TBL] [Abstract][Full Text] [Related]
22. Plasma cell leukemia: Retrospective review of cases at Monter Cancer Center/Northwell Health Cancer Institute, 2014-2019.
Cotte C; Hartley-Brown M
Curr Probl Cancer; 2022 Jun; 46(3):100831. PubMed ID: 35091270
[TBL] [Abstract][Full Text] [Related]
23. Clinical and cytogenetic characteristics of primary and secondary plasma cell leukemia under the new IMWG definition criteria: a retrospective study.
Guan J; Ma J; Chen B
Hematology; 2023 Dec; 28(1):2254556. PubMed ID: 37732631
[TBL] [Abstract][Full Text] [Related]
24. The prognostic significance of circulating plasma cells in newly diagnosed multiple myeloma patients.
Yao W; Yang H; You H; Shang J; Zhai Y; Yan Z; Yan S; Shi X; Yao Y; Wang J; Wang P; Xu Y; Jin S; Yan L; Wu D; Fu C
Front Oncol; 2023; 13():1266868. PubMed ID: 37799469
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological and laboratory parameters of plasma cell leukemia among Indian population.
Dubey H; Goel H; Verma S; Gupta S; Tanwar K; Rahul E; Kapoor G; Vasantharaman J; Ranjan A; Tanwar P; Chopra A
Am J Blood Res; 2022; 12(6):190-195. PubMed ID: 36742277
[TBL] [Abstract][Full Text] [Related]
26. Plasma cell leukemia: a report on 15 patients.
Bernasconi C; Castelli G; Pagnucco G; Brusamolino E
Eur J Haematol Suppl; 1989; 51():76-83. PubMed ID: 2697596
[TBL] [Abstract][Full Text] [Related]
27. Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma.
Gonsalves WI; Rajkumar SV; Gupta V; Morice WG; Timm MM; Singh PP; Dispenzieri A; Buadi FK; Lacy MQ; Kapoor P; Gertz MA; Kumar SK
Leukemia; 2014 Oct; 28(10):2060-5. PubMed ID: 24618735
[TBL] [Abstract][Full Text] [Related]
28. Plasma cell leukemia: from biology to treatment.
Jelinek T; Kryukov F; Rihova L; Hajek R
Eur J Haematol; 2015 Jul; 95(1):16-26. PubMed ID: 25778450
[TBL] [Abstract][Full Text] [Related]
29. A Clinical Perspective on Plasma Cell Leukemia: A Single-Center Experience.
Li AY; Kamangar F; Holtzman NG; Rapoport AP; Kocoglu MH; Atanackovic D; Badros AZ
Cancers (Basel); 2024 Jun; 16(11):. PubMed ID: 38893268
[TBL] [Abstract][Full Text] [Related]
30. Pretreatment
Abe Y; Narita K; Kobayashi H; Kitadate A; Miura D; Takeuchi M; O'uchi E; O'uchi T; Matsue K
Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1325-1333. PubMed ID: 30687892
[TBL] [Abstract][Full Text] [Related]
31. Secondary plasma cell leukemia: a multicenter retrospective study of 101 patients.
Jurczyszyn A; Castillo JJ; Avivi I; Czepiel J; Davila J; Vij R; Fiala MA; Gozzetti A; Grząśko N; Milunovic V; Hus I; Mądry K; Waszczuk-Gajda A; Usnarska-Zubkiewicz L; Dębski J; Atilla E; Beksac M; Mele G; Sawicki W; Jayabalan D; Charliński G; Gyula Szabo A; Hajek R; Delforge M; Kopacz A; Fantl D; Waage A; Crusoe E; Hungria V; Richardson P; Laubach J; Guerrero-Garcia T; Liu J; Vesole DH
Leuk Lymphoma; 2019 Jan; 60(1):118-123. PubMed ID: 29965787
[TBL] [Abstract][Full Text] [Related]
32. Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics.
García-Sanz R; Orfão A; González M; Tabernero MD; Bladé J; Moro MJ; Fernández-Calvo J; Sanz MA; Pérez-Simón JA; Rasillo A; Miguel JF
Blood; 1999 Feb; 93(3):1032-7. PubMed ID: 9920853
[TBL] [Abstract][Full Text] [Related]
33. Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic Profile.
Hofste Op Bruinink D; Kuiper R; van Duin M; Cupedo T; van der Velden VHJ; Hoogenboezem R; van der Holt B; Beverloo HB; Valent ET; Vermeulen M; Gay F; Broijl A; Avet-Loiseau H; Munshi NC; Musto P; Moreau P; Zweegman S; van de Donk NWCJ; Sonneveld P
J Clin Oncol; 2022 Sep; 40(27):3132-3150. PubMed ID: 35357885
[TBL] [Abstract][Full Text] [Related]
34. Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma.
Song GY; Jung SH; Kim K; Kim SJ; Yoon SE; Lee HS; Kim M; Ahn SY; Ahn JS; Yang DH; Kim HJ; Lee JJ
BMC Cancer; 2020 Aug; 20(1):803. PubMed ID: 32831058
[TBL] [Abstract][Full Text] [Related]
35. More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma.
Jelinek T; Bezdekova R; Zihala D; Sevcikova T; Anilkumar Sithara A; Pospisilova L; Sevcikova S; Polackova P; Stork M; Knechtova Z; Venglar O; Kapustova V; Popkova T; Muronova L; Chyra Z; Hrdinka M; Simicek M; Garcés JJ; Puig N; Cedena MT; Jurczyszyn A; Castillo JJ; Penka M; Radocha J; Mateos MV; San-Miguel JF; Paiva B; Pour L; Rihova L; Hajek R
J Clin Oncol; 2023 Mar; 41(7):1383-1392. PubMed ID: 36315921
[TBL] [Abstract][Full Text] [Related]
36. [Multiple myeloma: a proper selection of the treatment regimen for an individual patient].
Kanoh T
Nihon Rinsho; 1995 Mar; 53(3):671-7. PubMed ID: 7699903
[TBL] [Abstract][Full Text] [Related]
37. Single-Center Experience of Patients with Plasma Cell Leukemia in the Era of New Therapeutics.
Dampmann M; Flossdorf S; Keyl J; Reinhardt HC; Hanoun C
Acta Haematol; 2024 May; ():1-8. PubMed ID: 38763126
[TBL] [Abstract][Full Text] [Related]
38. [Clinical and cytogenetic characteristics of myeloma patients with overall survival less than 24 months].
Zhuang J; Tang W; Li H; Chen M; Han B; Zhu T; Duan M; Li J; Zhang W; Xu Y; Wang S; Zhao Y; Zhou D
Zhonghua Yi Xue Za Zhi; 2015 Mar; 95(10):736-40. PubMed ID: 26080843
[TBL] [Abstract][Full Text] [Related]
39. Secondary plasma cell leukemia.
Rotaru I; Găman G; Dumitrescu D; Foarfă C
Rom J Morphol Embryol; 2012; 53(4):1073-6. PubMed ID: 23303035
[TBL] [Abstract][Full Text] [Related]
40. Impact of extramedullary plasmacytomas on outcomes according to treatment approach in newly diagnosed symptomatic multiple myeloma.
Lee SE; Kim JH; Jeon YW; Yoon JH; Shin SH; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Lee JW; Min WS; Park CW; Min CK
Ann Hematol; 2015 Mar; 94(3):445-52. PubMed ID: 25257340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
